March 14, 2017 article Open access DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis The Lancet Oncology DOI: 10.1016/s1470-2045(17)30155-9 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 26 stored of 880 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification 2026 Nature Communications article Medicine Meningioma and schwannoma management Open access 0 citations Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes 2026 Nature Cancer article Computer Science AI in cancer detection Open access 3 citations Multidisciplinary management of meningiomas in the era of precision oncology 2026 Nature Reviews Clinical Oncology review Medicine Meningioma and schwannoma management 0 citations Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas 2026 Acta Neuropathologica Communications article Medicine Meningioma and schwannoma management Open access 0 citations The prognostic impact of CDKN2A/B hemizygous deletions in meningioma 2026 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 4 citations A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification 2026 Nature Genetics article Medicine Meningioma and schwannoma management Open access 10 citations Advancing CNS tumor diagnostics with expanded DNA methylation-based classification 2025 Cancer Cell article Medicine Glioma Diagnosis and Treatment Open access 42 citations Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas 2025 Journal of Neuropathology & Experimental Neurology article Medicine Meningioma and schwannoma management Open access 3 citations Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells 2025 Acta Neuropathologica article Immunology and Microbiology Immune cells in cancer Open access 7 citations Advancing CNS tumor diagnostics with expanded DNA methylation-based classification 2025 medRxiv preprint Medicine Glioma Diagnosis and Treatment Open access 8 citations Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles 2025 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 3 citations Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes 2025 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 15 citations Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma 2025 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Meningioma and schwannoma management Open access 6 citations European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection 2024 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 38 citations Meningiomas: Sex-specific differences and prognostic implications of a chromosome X loss 2024 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 13 citations Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma 2024 Nature Medicine article Medicine Meningioma and schwannoma management Open access 83 citations Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma 2024 Acta Neuropathologica article Medicine Meningioma and schwannoma management Open access 21 citations Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients 2024 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 151 citations The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review 2024 Neuro-Oncology Advances review Medicine Meningioma and schwannoma management Open access 3 citations Neuro-Orbital Disease 2024 Springer eBooks book-chapter Medicine Meningioma and schwannoma management 0 citations 1–20 of 26 Page 1 / 2 Next → References 0